|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.240 SEK | +3.33% |
|
+1.81% | -37.06% |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| 06-30 | IRLAB Therapeutics Rights Issue Raises About SEK 68 Mln | RE |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 10.48M | ||
| 35.95x | 21.65x | 0.73x | 13.06x | 26.6x | 27.42x | 0.55% | 1,097B | ||
| 27.63x | 6.96x | -1.82x | 6.35x | 17.27x | 19.08x | 2.06% | 622B | ||
| 31.37x | 973.81x | 0.13x | 7.5x | 15.34x | 15.74x | 2.72% | 449B | ||
| 18.05x | 6.7x | 1.06x | 4.48x | 11.03x | 12.44x | 2.96% | 334B | ||
| 23.74x | 5.53x | 1.08x | 4.94x | 14.01x | 14.74x | 1.76% | 294B | ||
| 21.75x | 6.51x | -50.18x | 5.59x | 13.5x | 14.78x | 2.83% | 286B | ||
| 13.9x | 6.03x | -8.48x | 5.17x | 10.63x | 12.45x | 3.6% | 213B | ||
| 23.5x | 17.9x | 3x | 6.26x | 11.01x | 14.32x | 2.8% | 195B | ||
| -45.11x | 8.01x | 0.32x | 5.46x | 30.35x | 60.97x | 2.57% | 157B | ||
| 28.57x | 5.73x | 2.02x | 8.75x | 19.72x | 20.53x | -.--% | 127B | ||
| 11.62x | 5.15x | 0.25x | 3.14x | 8.38x | 9.11x | 4.29% | 120B | ||
| 12.54x | 4.58x | 1.05x | 2.76x | 8.09x | 9.14x | 3.54% | 104B | ||
| 11.23x | 1.21x | 2.23x | 2.15x | 6.94x | 7.88x | 5.64% | 103B | ||
| 24.5x | 5.55x | 1.42x | 8.32x | 15.74x | 16.46x | 1.8% | 76.97B | ||
| 37.62x | 5.09x | 1.96x | 8.45x | 28.18x | 29.12x | 0.51% | 51.46B | ||
| 42.08x | 1.11x | 51.44x | 2.61x | 9.58x | 26.53x | 3.95% | 50.5B | ||
| 18.15x | 1.81x | 4.82x | 3.3x | 12.41x | 13.92x | 2.29% | 40.69B | ||
| 38.41x | 18.43x | 0.17x | 6.47x | 29.43x | 28.47x | -.--% | 39.19B | ||
| Average | 20.86x | 61.21x | 0.62x | 5.82x | 16.01x | 19.62x | 2.44% | 229.47B | |
| Weighted average by Cap. | 24.33x | 110.29x | -2.63x | 7.56x | 17.78x | 20.18x | 2.08% |
- Stock Market
- Stocks
- IRLAB A Stock
- Sector IRLAB Therapeutics AB
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















